Study of a new treatment for severe hair loss
Part of Skin clinical trials.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have alopecia areata that causes hair loss on 50% to 90% of your scalp
- Your current hair loss episode has lasted between 6 months and 4 years
- Your hair has not shown any significant regrowth in the last 6 months
- You agree not to use any other hair loss treatments during the study
- You do not have other forms of alopecia or diffuse hair shedding as your main symptom
- You are generally healthy and do not have unstable medical conditions requiring frequent hospitalizations
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
This trial tests an oral medication called NXC-736 for people with moderate to severe alopecia areata. It aims to see if the drug is safe and can help regrow hair.
This trial tests an experimental oral tablet (VC005) in teenagers with severe alopecia areata, a condition that causes patchy hair loss. The goal is to see if the drug is safe and may help regrow hair.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.